These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 33995347)

  • 21. Sjögren's syndrome: from pathogenesis to novel therapeutic targets.
    Barone F; Colafrancesco S
    Clin Exp Rheumatol; 2016; 34(4 Suppl 98):58-62. PubMed ID: 27586806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prospects of immunotropic therapy of traumatic uveitis].
    Valeeva RG; Grishina VS; Iluridze SL; Isaeva RT
    Vestn Oftalmol; 1998; 114(4):26-8. PubMed ID: 9771084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular phenotypes as inflammatory mediators in Parkinson's disease: Interventional targets and role of natural products.
    Jiang X; Ganesan P; Rengarajan T; Choi DK; Arulselvan P
    Biomed Pharmacother; 2018 Oct; 106():1052-1062. PubMed ID: 30119171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A20 Inhibits Intraocular Inflammation in Mice by Regulating the Function of CD4+T Cells and RPE Cells.
    Hu J; Yi S; Wang C; Zhang Y; Tang J; Huang X; Yang L; Yang J; Li H
    Front Immunol; 2020; 11():603939. PubMed ID: 33613524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation, counter-regulation, and immunotherapy of autoimmune responses to immunologically privileged retinal antigens.
    Caspi RR
    Immunol Res; 2003; 27(2-3):149-60. PubMed ID: 12857964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Significance of autoimmunity in various forms of uveitis].
    Zierhut M; Klein R; Berg P; Thiel HJ
    Klin Monbl Augenheilkd; 1991 Mar; 198(3):165-73. PubMed ID: 1829128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunomodulatory effects of Longdan Xiegan Tang on CD4+/CD8+ T cells and associated inflammatory cytokines in rats with experimental autoimmune uveitis.
    Tang K; Guo D; Zhang L; Guo J; Zheng F; Si J; Bi H
    Mol Med Rep; 2016 Sep; 14(3):2746-54. PubMed ID: 27485320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytokines and Biologics in non-infectious autoimmune uveitis: bench to bedside.
    Agrawal R; Iyer J; Connolly J; Iwata D; Teoh S
    Indian J Ophthalmol; 2014 Jan; 62(1):74-81. PubMed ID: 24492505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bench to bedside: new approaches to the immunotherapy of uveitic disease.
    Nussenblatt RB
    Int Rev Immunol; 2002; 21(2-3):273-89. PubMed ID: 12424847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical administration of a suppressor of cytokine signaling-1 (SOCS1) mimetic peptide inhibits ocular inflammation and mitigates ocular pathology during mouse uveitis.
    He C; Yu CR; Sun L; Mahdi RM; Larkin J; Egwuagu CE
    J Autoimmun; 2015 Aug; 62():31-8. PubMed ID: 26094775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carbon monoxide-releasing molecule-A1 (CORM-A1) improves clinical signs of experimental autoimmune uveoretinitis (EAU) in rats.
    Fagone P; Mangano K; Mammana S; Cavalli E; Di Marco R; Barcellona ML; Salvatorelli L; Magro G; Nicoletti F
    Clin Immunol; 2015 Apr; 157(2):198-204. PubMed ID: 25701800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunotherapeutic approaches in ocular inflammatory diseases.
    Kurup SK; Chan CC
    Arch Immunol Ther Exp (Warsz); 2005; 53(6):484-96. PubMed ID: 16407781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different composition of intraocular immune mediators in Posner-Schlossman-Syndrome and Fuchs' Uveitis.
    Pohlmann D; Schlickeiser S; Metzner S; Lenglinger M; Winterhalter S; Pleyer U
    PLoS One; 2018; 13(6):e0199301. PubMed ID: 29944680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A look at autoimmunity and inflammation in the eye.
    Caspi RR
    J Clin Invest; 2010 Sep; 120(9):3073-83. PubMed ID: 20811163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ocular autoimmunity: the price of privilege?
    Caspi RR
    Immunol Rev; 2006 Oct; 213():23-35. PubMed ID: 16972894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New observations and emerging ideas in diagnosis and management of non-infectious uveitis: A review.
    Rosenbaum JT; Bodaghi B; Couto C; Zierhut M; Acharya N; Pavesio C; Tay-Kearney ML; Neri P; Douglas K; Pathai S; Song AP; Kron M; Foster CS
    Semin Arthritis Rheum; 2019 Dec; 49(3):438-445. PubMed ID: 31301816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experimental autoimmune uveitis and other animal models of uveitis: An update.
    Bansal S; Barathi VA; Iwata D; Agrawal R
    Indian J Ophthalmol; 2015 Mar; 63(3):211-8. PubMed ID: 25971165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strategies for the treatment of intraocular inflammatory disease.
    Nussenblatt RB; Schiffman R; Fortin E; Robinson M; Smith J; Rizzo L; Csaky K; Gery I; Waldmann T; Whitcup SM
    Transplant Proc; 1998 Dec; 30(8):4124-5. PubMed ID: 9865319
    [No Abstract]   [Full Text] [Related]  

  • 39. Captopril suppresses inflammation in endotoxin-induced uveitis in rats.
    Ilieva I; Ohgami K; Jin XH; Suzuki Y; Shiratori K; Yoshida K; Kase S; Ohno S
    Exp Eye Res; 2006 Sep; 83(3):651-7. PubMed ID: 16698015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of TNFα regulation in uveitis: focus on RNA-binding proteins.
    Khera TK; Dick AD; Nicholson LB
    Prog Retin Eye Res; 2010 Nov; 29(6):610-21. PubMed ID: 20813201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.